journal
https://read.qxmd.com/read/38376666/precision-medicine-in-rheumatology-the-promise-of-ultrasound-guided-synovial-biopsy-barriers-to-its-implementation-in-the-united-states-and-proposed-solutions
#1
REVIEW
Diane Lewis Horowitz, Arthur M Mandelin, Darren Tabechian, Ami Ben-Artzi
PURPOSE OF REVIEW: In the clinical evaluation of inflammatory arthritis and the research into its pathogenesis, there is a growing role for the direct analysis of synovial tissue. Over the years, various biopsy techniques have been used to obtain human synovial tissue samples, and there have been progressive improvements in the safety, tolerability, and utility of the procedure. RECENT FINDINGS: The latest advancement in synovial tissue biopsy techniques is the use of ultrasound imaging to guide the biopsy device, along with evolution in the characteristics of the device itself...
February 20, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38372873/how-to-monitor-disease-activity-of-axial-spondyloarthritis-in-clinical-practice
#2
REVIEW
Anand Kumthekar, Nirali Sanghavi, Anuya Natu, Abhijeet Danve
PURPOSE OF REVIEW: Treatment guided by periodic and quantitative data assessment results in better outcomes compared to using clinical gestalt. While validated generic as well as specific disease activity measures for axial spondyloarthritis (axSpA) are available, there is vast scope to improve their actual utilization in routine clinical practice. In this review, we discuss available disease activity measures for axSpA, describe results from the survey conducted among general rheumatologists as well as Spondyloarthritis Research and Treatment Network (SPARTAN) members about disease activity measurement in daily practice, and discuss ways to improve axSpA disease activity using technological advances...
February 19, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38372872/thrombin-generation-assay-in-antiphospholipid-antibodies-positive-subjects-as-a-personalized-thrombotic-risk-assessment-state-of-the-art-and-perspectives
#3
REVIEW
Thomas Foret, Virginie Dufrost, Jeremy Lagrange, Patricia Costa, Guillaume Mourey, Thomas Lecompte, Nadine Magy-Bertrand, Veronique Regnault, Stéphane Zuily, Denis Wahl
PURPOSE OF THE REVIEW: Thrombotic risk assessment in antiphospholipid positive (aPL +) subjects is a major challenge, and the study of in vitro thrombin generation (thrombin generation assays (TGA)) could provide useful information. Activated protein C (APC) sensitivity is involved in thrombotic events in antiphospholipid syndrome patients. We summarized methods used to assess APC sensitivity with TGA and evaluated the prognostic role of APC resistance through literature search...
February 19, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38372871/effect-of-osteoporosis-treatments-on-osteoarthritis-progression-in-postmenopausal-women-a-review-of-the-literature
#4
REVIEW
Wang-Chun Ho, Chung-Chih Chang, Wen-Tien Wu, Ru-Ping Lee, Ting-Kuo Yao, Cheng-Huan Peng, Kuang-Ting Yeh
PURPOSE OF REVIEW: The purpose of this literature review was to determine if medications used to treat osteoporosis are also effective for treating osteoarthritis (OA). RECENT FINDINGS: A total of 40 relevant articles were identified. Studies were categorized into those (1) discussing estrogen and selective estrogen receptor modulators (SERMs), (2) bisphosphonates, (3) parathyroid hormone (PTH) analogs, and (4) denosumab, and (5) prior review articles. A large amount of evidence suggests that estrogen and SERMs are effective at reducing OA symptoms and disease progression...
February 19, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38340269/year-in-review-in-axial-spondyloarthritis-clinical-research-and-guidelines-spartan-2023-annual-meeting-proceedings
#5
REVIEW
Maureen Dubreuil
PURPOSE OF REVIEW: To highlight high impact clinical publications in spondyloarthritis from May 2022 to April 2023 that were summarized and presented at the SPARTAN annual meeting in May 2023. RECENT FINDINGS: Publications included updated guidelines on management of axial spondyloarthritis (axSpA) by ASAS-EULAR and development of a modified Juvenile Spondyloarthritis Disease Activity Index (JSpADA). Definitions were published for MRI lesions of the spine in axSpA and active and structural sacroiliac (SI) joint lesions in juvenile spondyloarthritis (JSpA)...
February 10, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38332457/dose-tapering-and-discontinuation-of-biologic-dmards-in-axial-spondyloarthritis-a-narrative-review-2023-spartan-annual-meeting-proceedings
#6
REVIEW
Haseeb Chaudhary, Mohamad Bittar, Ansaam Daoud, Marina Magrey
PURPOSE OF REVIEW: Limited data is available for tapering or discontinuation of biologic therapy in patients with axSpA who are in disease remission. The current review concentrates on published studies regarding dose tapering or withdrawal of biologics in axSpA. RECENT FINDINGS: Recent evidence in light of randomized controlled trials suggests that tapering of b-DMARDs is a feasible strategy to maintain remission or low disease activity in axSpA patients. TNF inhibitors were the studied biologics in most of these trials...
February 9, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38324125/sequence-of-events-in-the-pathogenesis-of-axial-spondyloarthritis-a-current-review-2023-spartan-meeting-proceedings
#7
REVIEW
Archita Srinath, Akihiro Nakamura, Nigil Haroon
PURPOSE OF REVIEW: Over the past two decades, significant progress has been made to untangle the etiology of inflammation and new bone formation (NBF) associated with axial spondyloarthritis (axSpA). However, exact mechanisms as to how the disease initiates and develops remain elusive. RECENT FINDINGS: Type 3 immunity, centered around the IL-23/IL-17 axis, has been recognized as a key player in the pathogenesis of axSpA. Multiple hypotheses associated with HLA-B*27 have been proposed to account for disease onset and progression of axSpA, potentially by driving downstream T cell responses...
February 7, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38300467/microbial-mechanisms-of-rheumatoid-arthritis-pathogenesis
#8
JOURNAL ARTICLE
Brenda J Seymour, Brendan E Allen, Kristine A Kuhn
PURPOSE OF REVIEW: Host-microbiome interactions have been implicated in the pathophysiology of rheumatoid arthritis (RA), but the data linking specific microbes to RA is largely associative. Here, we review recent studies that have interrogated specific mechanistic links between microbes and host in the setting of RA. RECENT FINDINGS: Several candidate bacterial species and antigens that may trigger the conversion of an anti-bacterial to an autoimmune response have been recently identified...
February 1, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38270842/broadening-the-scope-of-resilience-in-chronic-pain-methods-social-context-and-development
#9
REVIEW
John A Sturgeon, Caroline Zubieta, Chelsea M Kaplan, Jennifer Pierce, Anne Arewasikporn, P Maxwell Slepian, Afton L Hassett, Zina Trost
PURPOSE OF REVIEW: A wellspring of new research has offered varying models of resilience in chronic pain populations; however, resilience is a multifaceted and occasionally nebulous construct. The current review explores definitional and methodological issues in existing observational and clinical studies and offers new directions for future studies of pain resilience. RECENT FINDINGS: Definitions of pain resilience have historically relied heavily upon self-report and from relatively narrow scientific domains (e...
January 25, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38227172/understanding-spondyloarthritis-pathogenesis-the-promise-of-single-cell-profiling
#10
REVIEW
Joerg Ermann, Micah Lefton, Kevin Wei, Maria Gutierrez-Arcelus
PURPOSE OF REVIEW: Single-cell profiling, either in suspension or within the tissue context, is a rapidly evolving field. The purpose of this review is to outline recent advancements and emerging trends with a specific focus on studies in spondyloarthritis. RECENT FINDINGS: The introduction of sequencing-based approaches for the quantification of RNA, protein, or epigenetic modifications at single-cell resolution has provided a major boost to discovery-driven research...
January 16, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38214806/erosive-hand-osteoarthritis-recent-advances-and-future-treatments
#11
REVIEW
Marta B Bean, Marta Favero, Roberta Ramonda, Carla R Scanzello
PURPOSE OF THE REVIEW: Erosive hand osteoarthritis (EHOA) is an aggressive form of hand osteoarthritis that leads to significant disability, and recent data suggests that it is increasing in prevalence. This review provides an update of our current understanding of epidemiology, genetic associations, biomarkers, pathogenesis, and treatment of EHOA, with particular focus on studies published within the last 5 years. RECENT FINDINGS: New studies of EHOA have identified new genetic loci associated with disease, including variants in genes involved in inflammation and bone remodeling...
January 12, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38214805/twenty-years-of-spartan-from-inception-to-impact-spartan-2023-annual-meeting-proceedings
#12
REVIEW
Joerg Ermann, Atul Deodhar, Muhammad Asim Khan, Michael H Weisman, John D Reveille
PURPOSE OF REVIEW: This review takes a look at the past, present, and future of SPARTAN, the Spondyloarthritis Research and Treatment Network, an organization of North American healthcare professionals dedicated to advancing research, education, and patient care in spondyloarthritis. RECENT FINDINGS: In 2022, SPARTAN completed the Classification of Axial SpondyloarthritiS Inception Cohort (CLASSIC) study, a collaboration with the Assessment in SpondyloArthritis International Society (ASAS)...
January 12, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38157158/synovial-tissue-insights-into-heterogeneity-of-rheumatoid-arthritis
#13
REVIEW
Anna Helena Jonsson
PURPOSE OF REVIEW: Rheumatoid arthritis is one of the most common rheumatic and autoimmune diseases. While it can affect many different organ systems, RA primarily involves inflammation in the synovium, the tissue that lines joints. Patients with RA exhibit significant clinical heterogeneity in terms of presence or absence of autoantibodies, degree of permanent deformities, and most importantly, treatment response. These clinical characteristics point to heterogeneity in the cellular and molecular pathogenesis of RA, an area that several recent studies have begun to address...
December 29, 2023: Current Rheumatology Reports
https://read.qxmd.com/read/38133712/pipeline-therapies-for-gout
#14
REVIEW
Kevin Yip, Genna Braverman, Linda Yue, Theodore Fields
PURPOSE OF REVIEW: Despite effective available treatments, gout management is often unsuccessful in getting patients to target serum urate goal and in managing flares in the setting of comorbidities. Studies addressing future treatment options for short- and long-term management are reviewed. RECENT FINDINGS: URAT-1 blocking agents have been helpful but have had limitations related to effects on renal function, lack of efficacy with renal impairment, and potential to increase renal stones...
December 22, 2023: Current Rheumatology Reports
https://read.qxmd.com/read/38127092/temperature-mediated-neural-interventions-in-knee-osteoarthritis-a-review-of-cryoneurolysis-and-cooled-radiofrequency-ablation-with-ultrasound-guidance
#15
REVIEW
Christopher M Tidwell, Paul J DeMarco
PURPOSE OF REVIEW: Knee osteoarthritis is a debilitating chronic disease affecting nearly half of the world's population at some point in their lives. Treatment of pain and loss of function associated with this disease has been limited. In this review, we seek to explore how neural interventions with ultrasound guidance may be an emerging option for non-pharmacologic pain relief in patients with knee osteoarthritis. RECENT FINDINGS: Cryoneurolysis techniques have been demonstrated to provide pain relief out to 150 days post-treatment in knee osteoarthritis in select individuals...
December 21, 2023: Current Rheumatology Reports
https://read.qxmd.com/read/38060107/calcinosis-in-juvenile-dermatomyositis-epidemiology-pathogenesis-clinical-features-and-treatment-a-systematic-review
#16
REVIEW
Jucier Gonçalves Júnior, Samuel Katsuyuki Shinjo
PURPOSE OF REVIEW: We performed a systematic review of the literature on the epidemiology, pathogenesis, clinical and laboratory characterization, and treatment of calcinosis in patients with juvenile dermatomyositis (JDM). A qualitative systematic review was conducted from January 1975 to April 2023 according to the PRISMA protocol using three electronic databases: PubMed, Web of Science, and Scopus. Studies were analyzed based on the following eligibility criteria: at least one combination of the terms described in the search strategy appeared in the title, written in English, Portuguese, or Spanish, and addressed the epidemiology, pathogenesis, diagnosis, and treatment of calcinosis in juvenile dermatomyositis...
December 7, 2023: Current Rheumatology Reports
https://read.qxmd.com/read/38051494/role-of-ifn-%C3%AE-in-rheumatoid-arthritis
#17
REVIEW
Chung M A Lin, John D Isaacs, Faye A H Cooles
PURPOSE OF REVIEW: Type 1 interferons (IFN-I) are of increasing interest across a wide range of autoimmune rheumatic diseases. Historically, research into their role in rheumatoid arthritis (RA) has been relatively neglected, but recent work continues to highlight a potential contribution to RA pathophysiology. RECENT FINDINGS: We emphasise the importance of disease stage when examining IFN-I in RA and provide an overview on how IFN-I may have a direct role on a variety of relevant cellular functions...
December 5, 2023: Current Rheumatology Reports
https://read.qxmd.com/read/38102522/how-to-use-janus-kinase-inhibitors-in-the-treatment-of-rheumatoid-arthritis-a-clinical-assessment-of-risks-and-benefits
#18
REVIEW
Fatima K Alduraibi, Jasvinder A Singh
PURPOSE OF REVIEW: To provide an updated understanding of risks and benefits of Janus kinase inhibitors (JAKi) versus biologic disease-modifying antirheumatic drugs (bDMARDs) in the management of rheumatoid arthritis (RA). RECENT FINDINGS: Shared decision-making is needed in choosing between JAKi and bDMARDs. Cardiovascular disease, malignancy, and thromboembolic events guide this choice. In patients with active RA despite methotrexate use, tumor necrosis factor inhibitor is conditionally favored over JAKi for low-cardiovascular-risk patients and strongly favored in those with pre-existing cardiovascular disease or multiple cardiovascular risk factors...
December 2023: Current Rheumatology Reports
https://read.qxmd.com/read/37950822/hla-b-27-and-ankylosing-spondylitis-50-years-of-insights-and-discoveries
#19
REVIEW
Muhammad A Khan
PURPOSE OF REVIEW: To commemorate the 50th anniversary of the groundbreaking discovery of a remarkably strong association between HLA-B*27 and ankylosing spondylitis (AS). RECENT FINDINGS: In addition to HLA-B*27, more than 116 other recognized genetic risk variants have been identified, while epigenetic factors largely remain unexplored in this context. Among patients with AS who carry the HLA-B*27 gene, clonally expanded CD8 + T cells can be found in their bloodstream and within inflamed tissues...
December 2023: Current Rheumatology Reports
https://read.qxmd.com/read/37776482/a-review-of-difficult-to-treat-rheumatoid-arthritis-definition-clinical-presentation-and-management
#20
REVIEW
Carly Conran, Jason Kolfenbach, Kristine Kuhn, Christopher Striebich, Larry Moreland
PURPOSE OF REVIEW: A subset of patients with rheumatoid arthritis (RA) who fail multiple biologic therapies are deemed to have "difficult-to-treat" (D2T) RA. In 2021, a European Alliance of Associations for Rheumatology (EULAR) task force proposed a clinical definition of D2T RA. Here we review RA phenotypes and clinical assessment of RA, propose a different definition of D2T RA, discuss possible D2T RA risk factors, and summarize existing literature on the management of D2T RA. RECENT FINDINGS: High disease activity at the time of diagnosis or prior to treatment with a biologic is associated with the development of D2T RA...
December 2023: Current Rheumatology Reports
journal
journal
34704
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.